References
- Chen J, Zhao D, Zhu M, et al. Paeoniflorin ameliorates AGEs-induced mesangial cell injury through inhibiting RAGE/mTOR/autophagy pathway. Biomed Pharmacother. 2017; 89:1362–1369.
- Chen S, Chen H, Liu Q, et al. Effect of simvastatin on the expression of nephrin, podocin, and vascular endothelial growth factor (VEGF) in podocytes of diabetic rat. Int J Clin Exp Med. 2015;8:18225–18234.
- Huang SS, Ding DF, Chen S, et al. Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy. Sci Rep. 2017;7:45692.
- Jiang XS, Chen XM, Wan JM, et al. Autophagy protects against palmitic acid-induced apoptosis in podocytes in vitro. Sci Rep. 2017;7:42764.
- Jin Y, Liu S, Ma Q, et al. Berberine enhances the AMPK activation and autophagy and mitigates high glucose-induced apoptosis of mouse podocytes. Eur J Pharmacol. 2017;794:106–114.
- Jung E, Kim J, Ho KS, et al. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy. Eur J Pharmacol. 2015;761:116–124.
- Kang MK, Park SH, Kim YH, et al. Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2α-ATF-CHOP pathway in diabetic mice. Acta Pharmacol Sin. 2017;38:1129–1140.
- Lenoir O, Jasiek M, Henique C, et al. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis. Autophagy 2015;11:1130–1145.
- Li D, Lu Z, Xu Z, et al. Spironolactone promotes autophagy via inhibiting PI3K/AKT/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress. Bioscience Reports. 2016;36:e00355–e00315.
- Moon J, Lee CJ, Lee SH, et al. The impact of diabetes mellitus on vascular biomarkers in patients with end-stage renal disease. Yonsei Med J. 2017;58:75–81.
- Ozdemir BH, Ozdemir AA, Erdal R, et al. Rapamycin prevents interstitial fibrosis in renal allografts through decreasing angiogenesis and inflammation. Transpl P. 2011;43:524–526.
- Wang X, Tao Y, Huang Y, et al. Catalase ameliorates diabetes-induced cardiac injury through reduced p65/RelA-mediated transcription of BECN1. J Cell Mol Med. 2017;21(12):3420–3434.
- Wei J, Jiang H, Gao H, et al. Blocking mammalian target of rapamycin (mTOR) attenuates hif-1α pathways engaged-vascular endothelial growth factor (VEGF) in diabetic retinopathy. Cell Physiol Biochem. 2016;40:1570–1577.
- Xiao T, Guan X, Nie L, et al. Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice. Mol Cell Biochem. 2014;394:145–154.
- Xu Y, Liu L, Xin W, et al. The renoprotective role of autophagy activation in proximal tubular epithelial cells in diabetic nephropathy. J Diabetes Complications. 2015;29:976–983.
- Yuan T, Rafizadeh S, Gorrepati KD, et al. Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes. Diabetologia 2017;60:668–678.
- Zhang G, Lin L, Qi D, et al. The composition of a protein aggregate modulates the specificity and efficiency of its autophagic degradation. Autophagy 2017;14:1–9.
- Zhang Y, Ma KL, Liu J, et al. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy. Am J Physiol Endocrinol Metab. 2015;308:E1140–E1148.